Application

18576933 · COMPOUNDS FOR TARGETING DEGRADATION OF IRAK4 PROTEINS

Filed 2024-01-05 · Pending The official file ↗ · Art unit 1627 · Examiner Alison Azar Hastings Typical · C4 THERAPEUTICS, INC. · McCarter & English, LLP / Biogen MA

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

26.6 mo

to disposition n/a

Statutes raised

102 103 112 DP

2 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.